Cargando…

European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Detalles Bibliográficos
Autores principales: Medeiros, B C, Tian, L, Robenson, S, Laport, G G, Johnston, L J, Shizuru, J A, Miklos, D B, Arai, S, Benjamin, J E, Weng, W-K, Negrin, R S, Lowsky, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042305/
https://www.ncbi.nlm.nih.gov/pubmed/24879117
http://dx.doi.org/10.1038/bcj.2014.35
_version_ 1782318791887159296
author Medeiros, B C
Tian, L
Robenson, S
Laport, G G
Johnston, L J
Shizuru, J A
Miklos, D B
Arai, S
Benjamin, J E
Weng, W-K
Negrin, R S
Lowsky, R
author_facet Medeiros, B C
Tian, L
Robenson, S
Laport, G G
Johnston, L J
Shizuru, J A
Miklos, D B
Arai, S
Benjamin, J E
Weng, W-K
Negrin, R S
Lowsky, R
author_sort Medeiros, B C
collection PubMed
description
format Online
Article
Text
id pubmed-4042305
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-40423052014-06-12 European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation Medeiros, B C Tian, L Robenson, S Laport, G G Johnston, L J Shizuru, J A Miklos, D B Arai, S Benjamin, J E Weng, W-K Negrin, R S Lowsky, R Blood Cancer J Letter to the Editor Nature Publishing Group 2014-05 2014-05-30 /pmc/articles/PMC4042305/ /pubmed/24879117 http://dx.doi.org/10.1038/bcj.2014.35 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Letter to the Editor
Medeiros, B C
Tian, L
Robenson, S
Laport, G G
Johnston, L J
Shizuru, J A
Miklos, D B
Arai, S
Benjamin, J E
Weng, W-K
Negrin, R S
Lowsky, R
European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
title European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
title_full European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
title_fullStr European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
title_full_unstemmed European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
title_short European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
title_sort european leukemianet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042305/
https://www.ncbi.nlm.nih.gov/pubmed/24879117
http://dx.doi.org/10.1038/bcj.2014.35
work_keys_str_mv AT medeirosbc europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation
AT tianl europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation
AT robensons europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation
AT laportgg europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation
AT johnstonlj europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation
AT shizuruja europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation
AT miklosdb europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation
AT arais europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation
AT benjaminje europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation
AT wengwk europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation
AT negrinrs europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation
AT lowskyr europeanleukemianetclassificationintermediaterisk1cohortisassociatedwithpooroutcomesinadultswithacutemyeloidleukemiaundergoingallogeneichematopoieticcelltransplantation